| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLE |
Departments of Molecular Oncology (E.H.F., M.B.), Pathology (S.G., D.M.F.), Physiology (C.Z., G.I., H.S., J.H., S.B., J.R., R.A.D.C., L.P.-B., M.E.G.), and Safety Assessment (R.E.), Genentech Inc., South San Francisco, California 94080; and Department of Physiology (G.F.W.), Faculty of Medicine and Dentistry, The University of Western Ontario, London, Ontario N6A 5C1, Canada
Address all correspondence and requests for reprints to: Dr. Ellen Filvaroff, Department of Molecular Oncology, Genentech, Inc., MS 72B, 1 DNA Way, South San Francisco, California 94080. E-mail: filvarof{at}gene.com.
Fish stanniocalcin (STC) inhibits uptake of calcium and stimulates phosphate reabsorption. To determine the role of the highly homologous mammalian protein, STC-1, we created and characterized transgenic mice that express STC-1 under control of a muscle-specific promoter. STC-1 transgenic mice were smaller than wild-type littermates and had normal growth plate cartilage morphology but increased cartilage matrix synthesis. In STC-1 mice, the rate of bone formation, but not bone mineralization, was decreased. Increased cortical bone thickness and changes in trabeculae number, density, and thickness in STC-1 mice indicated a concomitant suppression of osteoclast activity, which was supported by microcomputed tomography analyses and histochemistry. Skeletal muscles were disproportionately small and showed altered function and response to injury in STC-1 mice. Electron microscopy indicated that muscle mitochondria were dramatically enlarged in STC-1 mice. These changes in STC-1 mice could not be explained by deficits in blood vessel formation, as vascularity in organs and skeletal tissues was increased as was induction of vascularity in response to femoral artery ligation. Our results indicate that STC-1 can affect calcium homeostasis, bone and muscle mass and structure, and angiogenesis through effects on osteoblasts, osteoclasts, myoblasts/myocytes, and endothelial cells.
This article has been cited by other articles:
![]() |
A. C.-M. Chang, J. Hook, F. A. Lemckert, M. M. McDonald, M.-A. T. Nguyen, E. C. Hardeman, D. G. Little, P. W. Gunning, and R. R. Reddel The Murine Stanniocalcin 2 Gene Is a Negative Regulator of Postnatal Growth Endocrinology, May 1, 2008; 149(5): 2403 - 2410. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Sazonova, K. A. James, C. R. McCudden, D. Segal, A. Talebian, and G. F. Wagner Stanniocalcin-1 secretion and receptor regulation in kidney cells Am J Physiol Renal Physiol, April 1, 2008; 294(4): F788 - F794. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Ichikawa, K Horie-Inoue, K Ikeda, B Blumberg, and S Inoue Vitamin K2 induces phosphorylation of protein kinase A and expression of novel target genes in osteoblastic cells J. Mol. Endocrinol., October 1, 2007; 39(4): 239 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yoshiko, G. A. Candeliere, N. Maeda, and J. E. Aubin Osteoblast Autonomous Pi Regulation via Pit1 Plays a Role in Bone Mineralization Mol. Cell. Biol., June 15, 2007; 27(12): 4465 - 4474. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chakraborty, H. Brooks, P. Zhang, W. Smith, M. R. McReynolds, J. B. Hoying, R. Bick, L. Truong, B. Poindexter, H. Lan, et al. Stanniocalcin-1 regulates endothelial gene expression and modulates transendothelial migration of leukocytes Am J Physiol Renal Physiol, February 1, 2007; 292(2): F895 - F904. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wu, Y. Yoshiko, and F. De Luca Stanniocalcin 1 Acts as a Paracrine Regulator of Growth Plate Chondrogenesis J. Biol. Chem., February 24, 2006; 281(8): 5120 - 5127. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C.-M. Chang, J. Cha, F. Koentgen, and R. R. Reddel The Murine Stanniocalcin 1 Gene Is Not Essential for Growth and Development Mol. Cell. Biol., December 1, 2005; 25(23): 10604 - 10610. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Yeung, K. P. Lai, H. Y. Chan, N. K. Mak, G. F. Wagner, and C. K. C. Wong Hypoxia-Inducible Factor-1-Mediated Activation of Stanniocalcin-1 in Human Cancer Cells Endocrinology, November 1, 2005; 146(11): 4951 - 4960. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Hasilo, C. R. McCudden, J. R. J. Gillespie, K. A. James, E. R. Hirvi, D. Zaidi, and G. F. Wagner Nuclear targeting of stanniocalcin to mammary gland alveolar cells during pregnancy and lactation Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E634 - E642. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Paciga, E. R. Hirvi, K. James, and G. F. Wagner Characterization of big stanniocalcin variants in mammalian adipocytes and adrenocortical cells Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E197 - E205. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. J. Hoenderop, B. Nilius, and R. J. M. Bindels Calcium Absorption Across Epithelia Physiol Rev, January 1, 2005; 85(1): 373 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Luo, M. D. Pisarska, and A. J. W. Hsueh Identification of a Stanniocalcin Paralog, Stanniocalcin-2, in Fish and the Paracrine Actions of Stanniocalcin-2 in the Mammalian Ovary Endocrinology, January 1, 2005; 146(1): 469 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Gagliardi, E. Y. W. Kuo, S. Raulic, G. F. Wagner, and G. E. DiMattia Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E92 - E105. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Paciga, G. E. DiMattia, and G. F. Wagner Regulation of Luteal Cell Big Stanniocalcin Production and Secretion Endocrinology, September 1, 2004; 145(9): 4204 - 4212. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Luo, K. Kawamura, C. Klein, and A. J. W. Hsueh Paracrine Regulation of Ovarian Granulosa Cell Differentiation by Stanniocalcin (STC) 1: Mediation through Specific STC1 Receptors Mol. Endocrinol., August 1, 2004; 18(8): 2085 - 2096. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Newton, D. M. French, M. Yan, G. D. Frantz, and V. M. Dixit Myodegeneration in EDA-A2 Transgenic Mice Is Prevented by XEDAR Deficiency Mol. Cell. Biol., February 15, 2004; 24(4): 1608 - 1613. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zlot, G. Ingle, J. Hongo, S. Yang, Z. Sheng, R. Schwall, N. Paoni, F. Wang, F. V. Peale Jr., and M. E. Gerritsen Stanniocalcin 1 Is an Autocrine Modulator of Endothelial Angiogenic Responses to Hepatocyte Growth Factor J. Biol. Chem., November 28, 2003; 278(48): 47654 - 47659. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yoshiko, N. Maeda, and J. E. Aubin Stanniocalcin 1 Stimulates Osteoblast Differentiation in Rat Calvaria Cell Cultures Endocrinology, September 1, 2003; 144(9): 4134 - 4143. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. McCudden, K. A. James, C. Hasilo, and G. F. Wagner Characterization of Mammalian Stanniocalcin Receptors. MITOCHONDRIAL TARGETING OF LIGAND AND RECEPTOR FOR REGULATION OF CELLULAR METABOLISM J. Biol. Chem., November 15, 2002; 277(47): 45249 - 45258. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |